Oregon Set to Receive Nearly $66 Million as Purdue and Sacklers Finalize Opioid Settlement

Purdue Pharma and the Sackler family have finalized a $7.4 billion national settlement for their role in fueling the opioid crisis, with Oregon set to receive nearly $66 million over 15 years for addiction treatment, prevention, and recovery programs. The agreement concludes nearly a decade of litigation by attorneys general from all 55 U.S. states and territories, who investigated Purdue and the Sacklers since 2016 over aggressive opioid marketing that contributed to the country’s largest drug crisis. As part of the settlement, the Sacklers are permanently barred from selling opioids in the United States and have paid more than $1.5 billion, while Purdue paid $900 million; additional Sackler payments of $500 million, $500 million, and $400 million are scheduled for May 2027, May 2028, and May 2029, respectively. The settlement follows Purdue’s September 2019 bankruptcy and will fund communities and claimants involved in the legal proceedings, supported by the public release of more than 30 million opioid business documents. Oregon Attorney General Dan Rayfield emphasized that the settlement holds the Sacklers accountable and directs resources to Oregon communities that bore the heaviest costs, acknowledging that while the funding does not erase past damage, it enables a long-term response to the crisis.

(Source：Daily Tidings)